Indraprastha Medical Corporation Ltd Faces Bearish Momentum Amid Technical Downgrade

Technical Trend Shift and Price Movement

Indraprastha Medical Corporation’s current price stands at ₹397.00, down from the previous close of ₹408.55, marking a daily decline of 2.83%. The stock’s 52-week high is ₹640.05, while the 52-week low is ₹307.90, indicating a wide trading range over the past year. Today’s intraday range was relatively narrow, with a high of ₹403.85 and a low of ₹394.00, suggesting subdued volatility despite the downward pressure.

The technical trend has shifted from mildly bearish to outright bearish, signalling increased selling momentum. This shift is corroborated by multiple technical indicators across different timeframes, which collectively point to a weakening price structure.

MACD and Momentum Indicators

The Moving Average Convergence Divergence (MACD) indicator remains bearish on the weekly chart and mildly bearish on the monthly chart. The weekly MACD histogram continues to show negative values, indicating that the short-term momentum is below the longer-term trend. The mildly bearish monthly MACD suggests that while the longer-term trend is still under pressure, it has not yet fully deteriorated to a strong sell signal.

Complementing the MACD, the Know Sure Thing (KST) indicator is bearish on the weekly timeframe and mildly bearish monthly, reinforcing the view of weakening momentum. The KST’s decline suggests that the stock’s price momentum is losing strength, which could lead to further downside if the trend persists.

RSI and Overbought/Oversold Conditions

The Relative Strength Index (RSI) on both weekly and monthly charts currently shows no clear signal, hovering in a neutral zone. This indicates that the stock is neither overbought nor oversold, implying that the recent price decline is not yet at an extreme level. However, the absence of a bullish RSI divergence suggests limited immediate upside potential.

Moving Averages and Bollinger Bands

Daily moving averages are firmly bearish, with the stock trading below its key short-term and medium-term averages. This confirms the downward price pressure and suggests that any rallies may face resistance near these averages. Additionally, Bollinger Bands on both weekly and monthly charts are bearish, with the price trending near the lower band. This positioning often signals sustained selling pressure and increased volatility to the downside.

Volume and Dow Theory Signals

On-Balance Volume (OBV) is mildly bearish on the weekly chart and neutral on the monthly chart, indicating that volume trends are not strongly supporting a reversal. The Dow Theory assessment is mildly bearish weekly and shows no clear trend monthly, reflecting uncertainty in the broader market sentiment for this stock.

Comparative Performance Versus Sensex

Despite the recent technical deterioration, Indraprastha Medical Corporation has delivered impressive long-term returns relative to the Sensex. Over the past year, the stock has gained 26.55%, significantly outperforming the Sensex’s 2.71% rise. Over three years, the stock’s return of 385.33% dwarfs the Sensex’s 28.58%, and over five and ten years, the stock has surged 642.06% and 693.21% respectively, compared to the Sensex’s 49.70% and 207.61% gains.

However, in the short term, the stock has underperformed the benchmark. Year-to-date, the stock is down 11.33%, slightly worse than the Sensex’s 10.78% decline. Over the past month, the stock’s 8.04% fall also trails the Sensex’s 9.13% drop, and in the last week, the stock’s marginal 0.14% loss contrasts with the Sensex’s sharper 4.98% decline. This short-term underperformance aligns with the bearish technical signals currently observed.

MarketsMOJO Grade and Market Capitalisation

MarketsMOJO has downgraded Indraprastha Medical Corporation’s mojo grade from Hold to Sell as of 30 January 2026, reflecting the deteriorating technical outlook. The company holds a mojo score of 37.0, which is relatively low and consistent with a sell recommendation. The stock is classified as a small-cap, which typically entails higher volatility and risk, factors that investors should weigh carefully given the current bearish momentum.

Outlook and Investor Considerations

The convergence of bearish signals across multiple technical indicators suggests that Indraprastha Medical Corporation is currently in a downtrend phase. The daily moving averages and Bollinger Bands indicate resistance to upward price movement, while the MACD and KST confirm weakening momentum. The neutral RSI and OBV readings imply that the stock is not yet oversold, leaving room for further declines.

Investors should be cautious and consider the recent downgrade in mojo grade as a warning sign. While the company’s long-term performance remains impressive, the short-term technical picture is unfavourable. Those holding the stock may want to monitor for signs of a reversal or stabilisation before adding to positions, while prospective buyers might wait for clearer bullish signals or a more attractive valuation.

Summary

Indraprastha Medical Corporation Ltd’s recent technical downgrade and bearish momentum indicators signal caution for investors. The stock’s price has declined notably, with multiple technical tools confirming a downtrend. While the company’s long-term returns remain robust, the short-term outlook is challenged by weak momentum and resistance at key moving averages. The MarketsMOJO Sell rating underscores the need for prudence, especially given the stock’s small-cap status and current market volatility.

Investors should closely monitor technical developments and consider alternative investment opportunities within the hospital sector or broader market until a clearer recovery signal emerges.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today